The Group's principal activities are the research, development and information services for antibodies and diagnostics. The Group has developed certain technologies to gather and provide information concerning antibodies and the distinction of molecules. The Group focuses on the development of fully human antibodies that can be used for research and diagnostics, as well as for treating diseases.The Group operations are divided into two segments: Therapeutic Antibodies, which develops drug candidates for commercial partners and AbD - Research Antibodies segment, which delivers antibodies to the research antibody market. The Group operates in Europe, Asia, USA, Canada and Other Countries.
Alacra Alerts:
Receive alerts on the latest reports on MorphoSys AG
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
